134 related articles for article (PubMed ID: 15705079)
1. International Prostate Symptom Scores in young asymptomatic American men.
Mueller ER; Latini J; Lux M; Kreder K; Fitzgerald MP
BJU Int; 2005 Mar; 95(4):554-6. PubMed ID: 15705079
[TBL] [Abstract][Full Text] [Related]
2. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a new treatment outcome score for men with LUTS.
Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
[TBL] [Abstract][Full Text] [Related]
4. Is questionnaire enough to assess number of nocturic episodes? Prospective comparative study between data from questionnaire and frequency-volume charts.
Ku JH; Hong SK; Kim HH; Paick JS; Lee SE; Oh SJ
Urology; 2004 Nov; 64(5):966-9. PubMed ID: 15533487
[TBL] [Abstract][Full Text] [Related]
5. Voiding frequency in a sample of asymptomatic American men.
Latini JM; Mueller E; Lux MM; Fitzgerald MP; Kreder KJ
J Urol; 2004 Sep; 172(3):980-4. PubMed ID: 15311017
[TBL] [Abstract][Full Text] [Related]
6. Association between lower urinary tract symptoms and erectile dysfunction.
Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
[TBL] [Abstract][Full Text] [Related]
7. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
[TBL] [Abstract][Full Text] [Related]
8. Lower urinary tract symptoms and risk of prostate cancer in Japanese men.
Matsubara A; Yasumoto H; Teishima J; Seki M; Mita K; Hasegawa Y; Yoshino T; Kato M; Usui T
Int J Urol; 2006 Aug; 13(8):1098-102. PubMed ID: 16903936
[TBL] [Abstract][Full Text] [Related]
9. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries.
Li MK; Garcia LA; Rosen R
BJU Int; 2005 Dec; 96(9):1339-54. PubMed ID: 16287456
[TBL] [Abstract][Full Text] [Related]
10. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
Lehrer S; Cesaretti J; Stone NN; Stock RG
BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
[TBL] [Abstract][Full Text] [Related]
11. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
12. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score.
Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T
Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930
[TBL] [Abstract][Full Text] [Related]
13. Natural history of voiding function after radical retropubic prostatectomy.
Namiki S; Ishidoya S; Saito S; Satoh M; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2006 Jul; 68(1):142-7. PubMed ID: 16777193
[TBL] [Abstract][Full Text] [Related]
14. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
15. Psychometric analysis of international prostate symptom score for female lower urinary tract symptoms.
Okamura K; Nojiri Y; Osuga Y; Tange C
Urology; 2009 Jun; 73(6):1199-202. PubMed ID: 19371926
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
Shao Q; Song J; Guo YW; Lu WC; Du LD
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
[TBL] [Abstract][Full Text] [Related]
17. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
Nickel JC; Elhilali M; Vallancien G;
BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
[TBL] [Abstract][Full Text] [Related]
18. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms.
Namiki S; Saito S; Ishidoya S; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Jul; 66(1):147-51. PubMed ID: 15992905
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study.
Glasser DB; Carson C; Kang JH; Laumann EO
Int J Clin Pract; 2007 Aug; 61(8):1294-300. PubMed ID: 17627708
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men.
Andersson SO; Rashidkhani B; Karlberg L; Wolk A; Johansson JE
BJU Int; 2004 Aug; 94(3):327-31. PubMed ID: 15291861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
